ESPR Esperion Therapeutics Inc

USD 2.21 +0.09 ( +4.25)%
Icon

Esperion Therapeutics Inc (ESPR) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.21

+0.09 (+4.25)%

USD 0.40B

6.04M

USD 8.13(+285.07%)

USD 6.50 (+194.12%)

Icon

ESPR

Esperion Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 2.21
+0.09 ( +4.25)%

Discussions

Loading...

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...